{
    "clinical_study": {
        "@rank": "137802", 
        "arm_group": [
            {
                "arm_group_label": "Therapeutic CPAP", 
                "arm_group_type": "Active Comparator", 
                "description": "Therapeutic CPAP"
            }, 
            {
                "arm_group_label": "control", 
                "arm_group_type": "Sham Comparator", 
                "description": "subtherapeutic CPAP using 4 cm water"
            }
        ], 
        "brief_summary": {
            "textblock": "We hypothesize that patients with untreated OSAS will have more visceral fat, fatty liver\n      and increased carotid artery thickness whereas treatment with CPAP may reduce the mesenteric\n      and liver fat, plasma lipids, carotid artery thickness."
        }, 
        "brief_title": "Effects of CPAP on Visceral Fat Thickness", 
        "completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Obstructive Sleep Apnea", 
        "condition_browse": {
            "mesh_term": [
                "Apnea", 
                "Sleep Apnea Syndromes", 
                "Sleep Apnea, Obstructive"
            ]
        }, 
        "detailed_description": {
            "textblock": "This proposed RCT will compare the effects of therapeutic CPAP versus subtherapeutic CPAP in\n      patients newly diagnosed with OSA with reference to visceral fat especially mesenteric fat\n      thickness, liver fat, carotid artery IMT, LPW thickness, plasma lipids and adipokines over a\n      treatment period of 3 months. The results of this study will advance our understanding of\n      the relative role of OSA and obesity in the pathogenesis of MetS and whether CPAP therapy\n      can improve these metabolic dysregulation."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  symptomatic patients with OSA of AHI >= 5/hr\n\n        Exclusion Criteria:\n\n          -  Recent or past history of myocardial infarction/stroke/heart failure, unstable\n             angina, underlying malignancy,\n\n          -  patients with clinical features of any active infection\n\n          -  those who require urgent CPAP treatment because of associated respiratory failure or\n             to prevent job loss through excessive daytime sleepiness (eg professional drivers,\n             those handling dangerous machinery)\n\n          -  moderate to severe valvular heart disease, cardiomyopathy, and previous diagnosis of\n             OSA and/or previous use of CPAP therapy."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "84", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01828281", 
            "org_study_id": "VF-CPAP"
        }, 
        "intervention": {
            "arm_group_label": [
                "Therapeutic CPAP", 
                "control"
            ], 
            "description": "All subjects will undergo ultrasound examination of the abdomen the day after overnight PSG and then at 3 months after completion of therapeutic or subtherapeutic CPAP treatment of 4 cm water.", 
            "intervention_name": "CPAP", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 8, 2013", 
        "location": {
            "contact": {
                "last_name": "Karen Yiu", 
                "phone": "852 26323532"
            }, 
            "facility": {
                "address": {
                    "city": "Hong Kong", 
                    "country": "China"
                }, 
                "name": "Respiratory Division"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomized Controlled Study on the Effects of CPAP on Visceral Fat Thickness, Carotid Intima-media Thickness and Adipokines in Patients With Obstructive Sleep Apnoea Syndrome", 
        "other_outcome": {
            "measure": "CPAP usage", 
            "safety_issue": "No", 
            "time_frame": "3 months"
        }, 
        "overall_contact": {
            "last_name": "Karen Yiu", 
            "phone": "852 26323532"
        }, 
        "overall_official": {
            "affiliation": "Chinese University of Hong Kong", 
            "last_name": "Hui David, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Hong Kong: Joint CUHK-NTEC Clinical Research Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "mesenteric fat thickness", 
            "safety_issue": "No", 
            "time_frame": "3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01828281"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Chinese University of Hong Kong", 
            "investigator_full_name": "Prof David Shu Cheong Hui", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "changes in adipokines", 
            "safety_issue": "No", 
            "time_frame": "3 months"
        }, 
        "source": "Chinese University of Hong Kong", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Chinese University of Hong Kong", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}